Why the study?
Does Connexin 43 gene therapy prevent persistent atrial fibrillation in a porcine model?
Does Connexin 43 gene therapy prevent persistent atrial fibrillation in a porcine model?
Connexin 43 gene therapy shows potential as a viable strategy for preventing atrial arrhythmias based on preclinical porcine data.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating in porcine model; human trials needed before clinical consideration.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Bikou et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: